Postherpetic Neuralgia Market Size
Market Size in USD Mn
CAGR6.5%
| Study Period | 2025-2032 |
| Base Year of Estimation | 2024 |
| CAGR | 6.5% |
| Market Concentration | Medium |
| Major Players | Pfizer Inc., GlaxoSmithKline plc, Novartis AG, Teikoku Pharma USA, Astellas Pharma Inc. and Among Others |
*Disclaimer: Major players are listed in no particular order.
*Source: Coherent Market Insights
Want to purchase customized report?
please let us know !
please let us know !
Postherpetic Neuralgia Market Analysis
The postherpetic neuralgia market is estimated to be valued at USD 805.3 Mn in 2025 and is expected to reach USD 1251.4 Mn by 2032, growing at a compound annual growth rate (CAGR) of 6.5% from 2025 to 2032. The increasing prevalence of Herpes Zoster infections globally is expected to drive the demand for treatment of postherpetic neuralgia.